What is Janux Therapeutics's operating lease liabilities?

Janux Therapeutics (JANX) reported operating lease liabilities of $19.1M in Q1 2026.

How has Janux Therapeutics's operating lease liabilities changed year-over-year?

Janux Therapeutics's operating lease liabilities decreased by 8.2% year-over-year, from $20.8M to $19.1M.

What does operating lease liabilities mean?

Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

Janux Therapeutics JANX Operating Lease Liabilities

Operating Lease Liabilities at other companies

XencorXNCR

$62.6M-2.5%

Vor BiopharmaVOR

$2.63M-90.1%

Cullinan Therapeutics, Inc.CGEM

$1.66M+236%

Nektar TherapeuticsNKTR

$60.63M-22.8%

ImmunomeIMNM

$3.69M-22.6%

CRISPR TherapeuticsCRSP

$183.56M-9.1%

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.1%

Enterprise value$862.55M-35.9%

P/S65×-84.6×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's operating lease liabilities?: Janux Therapeutics (JANX) reported operating lease liabilities of $19.1M in Q1 2026.
How has Janux Therapeutics's operating lease liabilities changed year-over-year?: Janux Therapeutics's operating lease liabilities decreased by 8.2% year-over-year, from $20.8M to $19.1M.
What does operating lease liabilities mean?: Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.